Not Tagged
abbvie
['#myelof', 'abbvie']
preliminary results from a phase 2 trial in #myelofibrosis (mf) will be shared at #asco22. mf is a rare blood cancer that develops when a genetic mutation occurs in blood stem cells. view more at : 
AbbVie’s Twitter feed featuring news and updates from our U.S. business. Intended for U.S. residents only. Review our guidelines here: https://t.co/CMljIbzTPP